RA0726

antibody from Oursmab

Targeting: TGFBR2 MFS2, TBR-ii, TBRII

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0726

Provider

Oursmab

Product name

Dalutrafusp (Biosimilar Reference Antibody) (TGFBR2)

Antibody type

Monoclonal

Description

Dalutrafusp alfa (AGEN-1423; GS-1423) is an investigational bifunctional antibody designed to simultaneously target two distinct immunosuppressive pathways within the tumor microenvironment. By inhibiting both CD73 and TGF-¦Â, it aims to reverse tumor-mediated immune suppression and restore effective anti-tumor immunity. This dual-targeting approach seeks to overcome the limitations of single-pathway inhibitors and is being evaluated in clinical trials for the treatment of advanced solid tumors.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.